Acepodia (ROCO:6976) Notes Receivable: NT$0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6976 Acepodia Inc ROCO:6976
11 GF Score
Price NT$12.60
! 3 Warning Signs
View Full Analysis

What is Acepodia Notes Receivable?

Acepodia ROCO:6976 +0.80% 11 Notes Receivable is NT$0.00 Mil as of Dec. 2025. GuruFocus rates ROCO:6976 with a GF Score™ of 11/100. The stock has 3 warning signs investors should review.

Acepodia's Notes Receivable for the quarter that ended in Dec. 2025 was NT$0.00 Mil.

Acepodia Notes Receivable Historical Data

* Premium members only.

The historical data trend for Acepodia's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acepodia Notes Receivable Chart

Acepodia Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Acepodia Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:6976
11GF Score
Acepodia Inc ROCO:6976
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acepodia Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of NT$0.00 Mil mean?
Acepodia (ROCO:6976) has a Notes Receivable of NT$0.00 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Acepodia and its competitors.
Is Acepodia's Notes Receivable too high?
Acepodia's current Notes Receivable is NT$0.00 Mil. Overall, Acepodia has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Acepodia's Notes Receivable compare to VRTX and REGN?
Acepodia's Notes Receivable of NT$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Acepodia and its competitors. Acepodia's current Notes Receivable is NT$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acepodia stock overvalued right now?
Acepodia (ROCO:6976) has a current Notes Receivable of NT$0.00 Mil. The current Notes Receivable is NT$0.00 Mil. Acepodia's overall GF Score™ is 11/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Acepodia (ROCO:6976), the current Notes Receivable is NT$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Acepodia Business Description

Address 17th floor-12, Number 99, Section 1, Xintai 5th Road, Xizhi District, New Taipei, TWN, 22175
Acepodia Inc is a clinical stage biotechnology company engaged to develop first-in-class cell therapies by using the Antibody-Cell Conjugation platform technology for cancer that are broadly accessible for patients.
11GF Score

Get the complete analysis for ROCO:6976

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$12.60
Price